Inhalation and Nasal Spray Generic Drugs Market
According to Intent Market Research, the Inhalation and Nasal Spray Generic Drugs Market is expected to grow from USD 29.3 Billion in 2024-e at a CAGR of 8.8% to touch USD 48.5 Billion by 2030. The Inhalation and Nasal Spray Generic Drugs Market is dominated by key players such as, Teva Pharmaceutical Industries Ltd., Sandoz (A Novartis Division), Cipla Limited, Mylan (now part of Viatris Inc.), Sun Pharmaceutical Industries Ltd., and Dr. Reddy–s Laboratories.